125 related articles for article (PubMed ID: 11576619)
1. Substrate interaction with 5alpha-reductase enzyme: influence of the 17beta-chain chirality in the mechanism of action of 4-azasteroid inhibitors.
Grisenti P; Magni A; Olgiati V; Manzocchi A; Ferraboschi P; Villani V; Pucciariello R; Celotti F
Steroids; 2001 Nov; 66(11):803-10. PubMed ID: 11576619
[TBL] [Abstract][Full Text] [Related]
2. Mechanism based representation of the active site of 5 alpha-reductase (5AR).
Ahmed S; Denison S
Bioorg Med Chem Lett; 1998 Sep; 8(18):2615-70. PubMed ID: 9873591
[TBL] [Abstract][Full Text] [Related]
3. Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.
Szécsi M; Ondré D; Tóth I; Magony S; Wölfling J; Schneider G; Julesz J
Acta Biol Hung; 2010 Sep; 61(3):274-81. PubMed ID: 20724274
[TBL] [Abstract][Full Text] [Related]
4. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
5. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
Tolman RL; Sahoo SP; Bakshi RK; Gratale D; Patel G; Patel S; Toney J; Chang B; Harris GS
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):303-9. PubMed ID: 9219921
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
7. Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids.
Thareja S; Rajpoot T; Verma SK
Steroids; 2015 Mar; 95():96-103. PubMed ID: 25582615
[TBL] [Abstract][Full Text] [Related]
8. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and 5α-reductase inhibitory activity of C₂₁ steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes.
Kim S; Kim YU; Ma E
Molecules; 2011 Dec; 17(1):355-68. PubMed ID: 22210173
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
[TBL] [Abstract][Full Text] [Related]
11. Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids.
Tian G; Haffner CD
J Biol Chem; 2001 Jun; 276(24):21359-64. PubMed ID: 11279132
[TBL] [Abstract][Full Text] [Related]
12. N-substituted 4-(4-carboxyphenoxy)benzamides. Synthesis and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2.
Picard F; Hartmann RW
J Enzyme Inhib Med Chem; 2002 Jun; 17(3):187-96. PubMed ID: 12443045
[TBL] [Abstract][Full Text] [Related]
13. Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study Review.
Thareja S
Chem Rev; 2015 Apr; 115(8):2883-94. PubMed ID: 25785489
[No Abstract] [Full Text] [Related]
14. Novel 17 substituted pregnadiene derivatives as 5 alpha-reductase inhibitors and their binding affinity for the androgen receptor.
Cabeza M; Flores E; Heuze I; Sánchez M; Bratoeff E; Ramírez E; Francolugo VA
Chem Pharm Bull (Tokyo); 2004 May; 52(5):535-9. PubMed ID: 15133203
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain.
Steckelbroeck S; Watzka M; Reichelt R; Hans VH; Stoffel-Wagner B; Heidrich DD; Schramm J; Bidlingmaier F; Klingmüller D
J Clin Endocrinol Metab; 2001 Mar; 86(3):1324-31. PubMed ID: 11238528
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the steroid binding domain of rat steroid 5alpha-reductase (isozyme-1): the steroid D-ring binding domain of 5alpha-reductase.
Bhattacharyya AK; Wang M; Rajagopalan K; Taylor MF; Hiipakka R; Liao S; Collins DC
Steroids; 1999 Mar; 64(3):197-204. PubMed ID: 10400380
[TBL] [Abstract][Full Text] [Related]
17. The enzyme and inhibitors of 4-ene-3-oxosteroid 5 alpha-oxidoreductase.
Li X; Chen C; Singh SM; Labrie F; Labire F [corrected to Labrie F]
Steroids; 1995 Jun; 60(6):430-41. PubMed ID: 7676475
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN
Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 17beta-N-substituted 19-Nor-10-azasteroids as inhibitors of human 5alpha-reductases I and II.
Scarpi D; Occhiato EG; Danza G; Serio M; Guarna A
Bioorg Med Chem; 2002 Nov; 10(11):3455-61. PubMed ID: 12213459
[TBL] [Abstract][Full Text] [Related]
20. 5 alpha-reductase in intact DU145 cells: evidence for isozyme I and evaluation of novel inhibitors.
Reichert W; Jose J; Hartmann RW
Arch Pharm (Weinheim); 2000 Jul; 333(7):201-4. PubMed ID: 10965593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
